Acadia Pharmaceuticals   Report issue

Contributed to NME For profit Phase 2 Phase 3 Phase 4
Founded: San Diego CA United States (1993)

Organization Overview

First Clinical Trial
2004
NCT00087542
First Marketed Drug
2016
pimavanserin (nuplazid)
First NDA Approval
2016
pimavanserin (nuplazid)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ACADIA Pharmaceuticals Inc. | ACADIA PHARMS INC